1-3 of 3
F. Zaja, MD
Close
Sort by
Journal Articles

Rituximab May Allow To Improve Multi-Organ Involvement in Patients with cGVHD.

Francesco F. Zaja, MD, Andrea A. Bacigalupo, MD, Alberto A. Bosi, MD, Rosanna R. Scimè, MD, Giovanna G. Milone, MD, Michele M. Falda, MD, C. Vener, MD, D. Laszlo, MD, E. P. Alessandrino, MD, F. Narni, MD, S. Sica, MD, A. Olivieri, MD, Alessandra A. Sperotto, MD, Renato R. Fanin, MD
Journal: Blood
Blood (2005) 106 (11): 3100.
https://doi.org/10.1182/blood.V106.11.3100.3100
Published: 2005
Journal Articles

V H and V L Genes in Hairy Cell Leukemia Reveal a Dynamic On-Going Modification of the Surface B-Cell Receptor.

Francesco Forconi, MD, DM, PhD, T. Amato, D. Raspadori, BSci, S. S. Sahota, PhD, M. A. Dell’Aversano, M. Tassi, D. Rossi, MD, M. Bocchia, MD, M. Lenoci, MD, L. Rigacci, MD, F. Zaja, MD, G. Gaidano, MD, PhD, L. Leoncini, MD, Francesco Lauria, MD
Journal: Blood
Blood (2005) 106 (11): 287.
https://doi.org/10.1182/blood.V106.11.287.287
Published: 2005
Journal Articles

Earlier Administration of Rituximab Allows Higher Rate of Long-Lasting Response in Adult Patients with Autoimmune Thrombocytopenia.

Francesco F. Zaja, MD, Nicola N. Vianelli, MD, Marta M. Battista, MD, Alessandra A. Sperotto, MD, Francesca F. PAtriarca, MD, Valentina V. Tomadini, MD, Carla C. Fili, MD, M. Tani, MD, Michele M. Baccarani, MD, Renato R. Fanin, MD
Journal: Blood
Blood (2005) 106 (11): 3991.
https://doi.org/10.1182/blood.V106.11.3991.3991
Published: 2005